Neuroscience PhD: Mapping Neuronal Types Across Brain Development and Disease

Neuroscience PhD: Mapping Neuronal Types Across Brain Development and Disease

Quick Decision

This four-year MRC FGx-DLA PhD would build reference maps of human neuronal subtypes across brain regions and life stages. The student would use existing multiomic data to select cell-nucleus markers, develop fluorescence-activated nuclear sorting (FANS), and combine sorted populations with epigenomic and long-read assays. The maps would then inform analyses of human genetic signals and bulk brain disease data.

Applicants with backgrounds in genetics, neuroscience, molecular or biomedical science, bioinformatics, computing or statistics may fit. Exeter lists 5 January 2027 as the current deadline; an earlier captured advert lists 8 December 2026. For international applicants, the national FGx-DLA page says Exeter students need not top up UKRI funding for international fees, while local award pages state UK tuition. Ask admissions to confirm both the operative deadline and written fee terms. The proposed regions, ages, cell types and assays span a wide scope; sample availability and the four-year core plan should be discussed before accepting an offer.

Research Problem and Doctoral Work

What is unresolved and why it matters

Human brain tissue contains mixed cell populations. Bulk measurements can blur signals from neuronal subtypes with distinct molecular programs, while many single-cell datasets emphasize transcription and leave aspects of regulatory DNA, chromatin and full-length RNA less resolved. The project's premise is that more detailed reference maps of specific neuronal populations can help explain how cell identity varies by region, development and ageing, and how selected populations are affected in brain disease. These maps could also make it easier to interpret genetic associations and bulk-tissue molecular changes.

Advertised work and methods

The project PDF describes a sequence of linked tasks:

1. Use existing single-cell and multiomic datasets to identify nuclear markers that distinguish neuronal populations.
2. Develop fluorescence-activated nuclei sorting (FANS) strategies to isolate neuronal groups, including excitatory and inhibitory subtypes and regionally specialised examples such as motor neurons.
3. Profile material from the cortex, hippocampus, amygdala, hypothalamus and other disease-relevant regions, with opportunities to compare development and ageing.
4. Characterise regulatory and transcriptomic features using Oxford Nanopore long-read sequencing to map DNA modifications, ATAC-seq for accessible regulatory regions, and CUT&Tag for H3K27ac-marked active enhancers and promoters. The project highlights direct measurement of DNA hydroxymethylation (5hmC), which is abundant in neurons. Long-read RNA sequencing is intended to resolve full-length transcripts and cell-specific isoform use.
5. Integrate the resulting maps with human genetic evidence, including whole-genome sequencing and association datasets, and develop computational approaches to estimate specific neuronal population proportions and molecular states in bulk brain data. The project proposes applying such deconvolution to existing disease methylation datasets, including Alzheimer's disease.

The project description also mentions direct RNA sequencing and neuronal epitranscriptomics as possible avenues to explore. These are presented as opportunities, not confirmed core deliverables. Likewise, the project lists post-mortem tissue across regions and developmental stages, existing multiomic datasets, sorting platforms, sequencing facilities and high-performance computing as supporting resources. Their volume, student access and reserved capacity are not specified.

Feasibility and scientific trade-offs

Recent technical work from the Exeter team provides a direct starting point. An October 2026 study presents FANS protocols for separating major human and mouse brain cell types and preparing sorted nuclei for methylation, RNA, chromatin-accessibility and histone-mark assays. It also reports that yields can fall with rare cell groups and small brain regions, sometimes making it difficult to perform several assays from a single sample. That is especially relevant here because the advertised scope spans multiple subtypes, regions, ages and technologies.

Cell-composition deconvolution is a plausible bridge between sorted reference data and larger bulk cohorts, but its estimates depend on which cell types are represented in the reference, how specific the marker sites are, and how technical and biological confounding are handled. Estimated proportions are not direct cell counts. A key scientific discussion is therefore how reference maps will be validated and how the thesis will prioritize a manageable subset of the advertised scope.

School, Programme and Field Context

The project is based at the University of Exeter in its Department of Clinical and Biomedical Sciences, and the official application route is through Exeter. The programme page lists Exeter, Cambridge, Edinburgh, Imperial, King's and Oxford as six core institutions in the FGx-DLA, with shared training and often inter-institutional supervisory teams. The project PDF names collaborators at Imperial (Nott), King's (Marzi), Cambridge (Ryten) and EMBL-EBI (Birney). It does not specify their individual work packages, placement arrangements or degree-awarding roles; the documented application and project base is Exeter, and no joint or double degree is stated.

Exeter's published 2027 overall ranking is 136th in QS and 11th in the Complete University Guide. Those are whole-university indicators, not rankings of this research group. In REF 2021, Exeter's Clinical Medicine unit received an overall profile of 45% 4-star and 48% 3-star; this provides related subject context but is not an evaluation of the specific project or its supervisors. Locally, Clinical and Biomedical Sciences has a Genetics, Genomics and Epigenetics theme covering genomic and epigenomic variation, functional genomics and long-read transcript work, alongside neuroscience/CNS disease and data-science themes. Exeter also describes a Sequencing Facility with genomics and bioinformatics services. These sources show relevant institutional activity, but they do not guarantee specific instrument access or project capacity.

The FGx-DLA offers four years full-time, with part-time study also available. The current page does not state this project's detailed registration/upgrade route, cohort schedule, or part-time duration; confirm these with admissions before accepting an offer. The programme's national cohort, shared training and research network may be valuable for an applicant who wants exposure across experimental and computational functional genomics.

Supervisor and Lab Assessment

Supervisor research directions

Jonathan Mill is the named lead supervisor and contact. His NIHR Exeter profile describes him as Professor of Epigenomics and head of the Complex Disease Epigenomics Group, using integrated genomics to study molecular variation in central nervous system and complex disease. Emma Dempster's profile describes related brain genomics and neurodegeneration work. The project PDF also names Rosemary Bamford in the Exeter-based team. It does not allocate day-to-day supervisory responsibilities among them, so the applicant should ask who leads each workstream and how often the team meets.

Recent important publications

• Chioza et al. (2026), FANS methods. The team optimized fluorescence-activated nuclei sorting for epigenomic study of cortical cell types. It is the closest practical precedent for the proposed cell-isolation and parallel-assay work. Its report of lower yields in smaller regions and rarer populations is also a useful feasibility caveat; outcomes need not transfer uniformly to every target subtype.
• Franklin et al. (2025), human cortical methylation over the life course. This study profiled DNA-methylation dynamics in prenatal and postnatal human cortex, spanning development and ageing. It supports the team's experience with age-related human brain methylation, while leaving the proposed project's additional subtype and multi-region resolution as a further step.
• Leung et al. (2024), long-read isoform analysis in tau pathology. Using Oxford Nanopore and PacBio long reads, the study identified transcript diversity and isoform changes in a tau mouse model and followed selected signals in human cortex. It demonstrates relevant expertise in long-read transcript analysis. The main discovery was in a model system, human validation used fewer samples, and the paper notes limited sensitivity for rare transcripts.
• Hannon et al. (2024), cortical cell-composition estimation. The authors tested an expanded DNA-methylation reference panel with neuronal and glial subtypes. This directly informs the proposed deconvolution aim, while underscoring that estimates depend on reference-panel breadth and modeling assumptions.
• Bamford et al. (2025), cell-type-specific methylation study design. This methods guidance discusses design and analysis issues such as confounding and deconvolution. It is useful for planning reliable disease analyses, but is methodological guidance rather than a result from the proposed student's work.

Resources and collaboration environment

The project states that human post-mortem samples, existing brain multiomics, cell-sorting platforms, sequencing and HPC support it. The university facility page independently confirms general sequencing and bioinformatics services, and the national initiative describes a coordinated data infrastructure. These broad resource statements are encouraging; applicants should still ask which samples, platforms, assay slots, compute resources and training are committed to this project. The named partners may broaden expertise, but the expected frequency and form of their involvement are not public.

Funding, Application, and Living Cost

Item	Current published information	What remains to verify
Scheme and start	MRC FGx-DLA, September 2027 entry; applications opened 26 October 2026	Confirm the live portal record before submission
Deadline	Official programme and award pages list 5 January 2027	Corrected input retains 8 December 2026 from a captured advertisement; ask admissions if the portal or project PDF displays a different cutoff
Duration	Four years full-time; part-time study is available	Exact part-time duration and project-specific registration/upgrade route
Tuition and stipend	UK tuition fees plus UK Research Council minimum stipend, stated as £21,805 per year for 2026/27, updated annually	The 2027/28 stipend is not yet stated; the national FGx-DLA page says Exeter awardees do not top up international fees, while local Exeter pages list UK tuition only—confirm in writing
Additional support	Up to £5,000 per year for research training and support	This is research support, not extra living-cost income; ask which expenses it may cover
Eligibility	Minimum 2:1 honours degree or international equivalent in relevant subjects, including genetics, molecular biology, biomedical science, human biology, biochemistry, medicine/health professions, bioinformatics, computer science or statistics	Confirm equivalence and accepted subject classification with admissions
Application	One application per person; up to three project preferences; online form and FGx-DLA questionnaire; two referees who are not on the prospective supervisory team; all documents in English	Confirm exact submission and referee timing in the portal
English	Typically IELTS 7.0 overall with no component below 6.5, or equivalent	Confirm accepted equivalents or any exemption

Exeter estimates basic single-student costs at £1,300–£2,000 per month, based on average local spending in April 2026. At the current £21,805 stipend reference, the monthly equivalent is about £1,817 before personal budgeting; that is near the lower end of the estimated range and below its midpoint. It is a comparison, not a quoted take-home wage or a guaranteed 2027/28 amount. For context, listed university rooms in 2026/27 include Cook Mews at £5,470.74 for 44 weeks and Llewellyn Mews at £6,343.92 for 51 weeks. Availability, utilities/food coverage and the full-year budget need checking. International students should also budget separately for visa and arrival costs; Student visa eligibility depends on an unconditional offer from a licensed sponsor and a Confirmation of Acceptance for Studies.

Applicant Fit and Preparation

Required background and skills

The formal published threshold is the scheme's 2:1 or equivalent in a relevant subject, plus the applicable English-language requirement. The project description does not state a mandatory prior qualification in FANS, Oxford Nanopore sequencing, 5hmC or a particular programming language. Do not treat every advertised method as an admission prerequisite.

Useful preparation

Applicants can strengthen their case by explaining relevant work in cell or molecular biology, neuroscience, genetics, epigenetics, sequencing, bioinformatics or statistics. A short example that shows how they handled a research question, data quality or biological heterogeneity can demonstrate readiness for a project joining wet-lab and computational methods. Where relevant, be ready to discuss reproducible analysis in Python or R, statistical reasoning, and how to interpret limitations in human tissue data. These are preparation suggestions inferred from the advertised work, not additional official entry requirements.

The questionnaire asks why the applicant wants the FGx-DLA, an achievement they value, what research has taught them, and how they used generative AI if applicable. Strong responses should be specific and truthful, with examples of independent contribution, reflection and collaboration. Arrange two referees outside the prospective supervisory team, and prepare certified translations of qualifications if required.

Next Actions and Questions to Verify

Before applying

• Ask admissions to confirm the live deadline and whether the earlier 8 December 2026 date has any separate significance; current official pages show 5 January 2027.
• If applying as an international student, ask admissions to confirm in writing that the national FGx-DLA no-top-up statement applies to this award and fee classification; Exeter’s local 2027 pages state UK tuition only.
• Confirm that the degree subject, grade equivalence and English evidence meet scheme requirements, and check which documents must be uploaded by the deadline.
• Prepare one coherent application with up to three preferences, rather than separate applications.

At interview

• Which neuronal populations, regions and age groups are the committed thesis core, and which are stretch goals?
• Which assays are required deliverables, and which are optional—especially direct RNA and epitranscriptomic work?
• How will limited yields from rare populations or small regions be handled, and how many assays can reasonably be run per donor/sample?
• What is the intended balance of FANS and wet-lab work, sequencing, statistical analysis and computational deconvolution? What coding skills are expected at entry, and what training is provided?
• Who will supervise each component, and what specific roles will the partner institutions play?
• Which human samples, sequencing capacity and HPC resources are already approved for the project?

Before accepting an offer

• Confirm doctoral registration, milestones, supervision arrangements and the four-year/part-time terms in writing.
• Confirm the 2027/28 stipend, payment schedule, tuition coverage and what the annual research-support allowance can pay for.
• Make a realistic Exeter budget including rent, bills, travel, visa/IHS if relevant and one-off arrival expenses.

Evidence and Sources

Core Institutional and Programme Sources

• Official project PDF: Decoding cellular diversity in the brain
• MRC FGx-DLA programme, 2027 deadline and application terms
• Exeter award page, reference 6025
• FGx-DLA international-fee contribution guidance
• UK Human Functional Genomics Initiative: about
• Clinical and Biomedical Sciences research themes
• Genetics, Genomics and Epigenetics research theme
• Exeter Medical School research facilities
• Exeter rankings and league tables
• REF 2021 Exeter Clinical Medicine profile
• Exeter PhD and research-degree duration guidance
• UK Human Functional Genomics Initiative

Supervisor and Publication Sources

• Jonathan Mill profile, NIHR Exeter Biomedical Research Centre
• Emma Dempster profile, NIHR Exeter Biomedical Research Centre
• Chioza et al. (2026), optimized FANS for cortical cell types
• Franklin et al. (2025), human cortical DNA methylation across development and ageing
• Leung et al. (2024), long-read isoform analysis in tau pathology
• Hannon et al. (2024), methylation-based estimates of human cortical cell proportions
• Bamford et al. (2025), cell-type-specific methylation study-design guidance
• Zeng et al. (2026), single-nucleus atlas of cell-type-specific brain regulation

Funding, Application, Cost and Market Sources

• Exeter budgeting guide for international students
• Cook and Llewellyn Mews 2026/27 room information
• UKRI studentship stipend guidance
• Skills England life-sciences sector skills needs assessment
• National Careers Service: data scientist
• Prospects: life-sciences research scientist
• UK Student visa: course requirements